118 related articles for article (PubMed ID: 17006261)
1. Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma: Results from IRS IV.
Arndt CA; Hammond S; Rodeberg D; Qualman S
J Pediatr Hematol Oncol; 2006 Sep; 28(9):563-7. PubMed ID: 17006261
[TBL] [Abstract][Full Text] [Related]
2. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
3. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
[TBL] [Abstract][Full Text] [Related]
4. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Jenney M; Oberlin O; Audry G; Stevens MC; Rey A; Merks JH; Kelsey A; Gallego S; Haie-Meder C; Martelli H
Pediatr Blood Cancer; 2014 Feb; 61(2):217-22. PubMed ID: 23997024
[TBL] [Abstract][Full Text] [Related]
5. Presence of well-differentiated rhabdomyoblasts at the end of therapy for pelvic rhabdomyosarcoma: implications for the outcome.
Ortega JA; Rowland J; Monforte H; Malogolowkin M; Triche T
J Pediatr Hematol Oncol; 2000; 22(2):106-11. PubMed ID: 10779022
[TBL] [Abstract][Full Text] [Related]
6. Does the less aggressive multimodal approach of treating bladder-prostate rhabdomyosarcoma preserve bladder function?
Soler R; Macedo A; Bruschini H; Puty F; Caran E; Petrilli A; Garrone G; Srougi M; Ortiz V
J Urol; 2005 Dec; 174(6):2343-6. PubMed ID: 16280839
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
Rodeberg DA; Anderson JR; Arndt CA; Ferrer FA; Raney RB; Jenney ME; Brecht IB; Koscielniak E; Carli M; Bisogno G; Oberlin O; Rey A; Ullrich F; Stevens MC; Meyer WH
Int J Cancer; 2011 Mar; 128(5):1232-9. PubMed ID: 20473932
[TBL] [Abstract][Full Text] [Related]
8. Current standards of care in bladder and prostate rhabdomyosarcoma.
Kieran K; Shnorhavorian M
Urol Oncol; 2016 Feb; 34(2):93-102. PubMed ID: 26776454
[TBL] [Abstract][Full Text] [Related]
9. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
[TBL] [Abstract][Full Text] [Related]
10. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
Smith LM; Anderson JR; Coffin CM
Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
[TBL] [Abstract][Full Text] [Related]
11. Post-chemotherapy microscopic residual prostate rhabdomyosarcoma: long-term conservative follow-up.
Chertin B; Reinus C; Koulikov D; Rosenmann E; Farkas A; Chertin B
Pediatr Surg Int; 2002 Jan; 18(1):68-9. PubMed ID: 11793070
[TBL] [Abstract][Full Text] [Related]
12. [Prostate-bladder rhabdomyosarcoma: therapeutic approaches].
Vesga Molina F; Albisu Tristan A; Blasco de Villalonga M; Llarena Ibarguren R; Pertusa Peña C
Arch Esp Urol; 1994 Dec; 47(10):985-9. PubMed ID: 7864680
[TBL] [Abstract][Full Text] [Related]
13. [Rhabdomyosarcoma of the prostate and bladder in a child: radical or conservative surgery?].
Carvajal Busslinger MI; Plaschkes J
Helv Chir Acta; 1994 Dec; 60(6):1097-100. PubMed ID: 7875988
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV.
Rodeberg D; Arndt C; Breneman J; Lyden E; Donaldson S; Paidas C; Andrassy R; Meyer W; Wiener E
J Pediatr Surg; 2005 Jan; 40(1):256-62. PubMed ID: 15868594
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
16. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O
J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742
[TBL] [Abstract][Full Text] [Related]
17. Pediatric bladder/prostate rhabdomyosarcoma: Eight cases from a single center.
Emir S; Özdemir Sİ; Demir HA; Özyörük D; Karakuş E; Tiryaki T; Çetindağ F
Turk J Pediatr; 2016; 58(3):254-258. PubMed ID: 28266189
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in children undergoing salvage surgery for bladder/prostate rhabdomyosarcoma.
Angelini L; Bisogno G; Alaggio R; Scarzello G; Santoro L; Zanetti I; Scagnellato A; Basso E; D'Angelo P; Ferrari A; Castagnetti M
J Pediatr Urol; 2016 Aug; 12(4):265.e1-8. PubMed ID: 27255731
[TBL] [Abstract][Full Text] [Related]
19. [Conservative therapy in genitourinary rhabdomyosarcomas in children].
Sarnacki S; Flamant F; Valayer J
Chir Pediatr; 1987; 28(6):299-305. PubMed ID: 3447769
[TBL] [Abstract][Full Text] [Related]
20. Cystosarcoma phyllodes of the prostate with rhabdomyoblastic differentiation.
De Raeve H; Jeuris W; Wyndaele JJ; Van Marck E
Pathol Res Pract; 2001; 197(10):657-62. PubMed ID: 11700886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
